SCHEMBL16976010

SCHEMBL16976010

COCCCCC(C(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
DDAH1 O94760 2/20 0.39
TSHR P16473 1/20 0.38
GPR84 Q9NQS5 3/20 0.35
FFAR1 O14842 1/20 0.35
MAPT P10636 2/20 0.34
LCK P06239 1/20 0.34
PPARD Q03181 1/20 0.34
ZDHHC20 Q5W0Z9 1/20 0.34
ZDHHC2 Q9UIJ5 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
HPGD P15428 1/20 0.33
TBXAS1 P24557 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RECQL P46063 1/20 0.33
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3327687 0.93 ALDH1A1 (0.48) ALDH1A1DDAH1TSHRHPGDTDP1
SCHEMBL14667675 0.89 ALDH1A1 (0.47) ALDH1A1DDAH1TSHRGPR84FFAR1
SCHEMBL16411854 0.86 ALDH1A1 (0.48) ALDH1A1DDAH1TSHRGPR84FFAR1
SCHEMBL2634911 0.82 ALDH1A1 (0.41) ALDH1A1DDAH1TSHRHPGDTDP1
SCHEMBL12972386 0.82 LTA4H (0.50) ALDH1A1TBXAS1
SCHEMBL3124110 0.82 GPR84 (0.57) ALDH1A1DDAH1TSHRGPR84FFAR1
SCHEMBL28065252 0.82 LTA4H (0.50) ALDH1A1TBXAS1
SCHEMBL14628724 0.80 ALDH1A1 (0.52) ALDH1A1TBXAS1
SCHEMBL18641836 0.80 ALDH1A1 (0.52) ALDH1A1TBXAS1
SCHEMBL8469936 0.80 RNPEP (0.55) ALDH1A1DDAH1TSHRGPR84FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9555008-B2 Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-01-31 US disclosed
US-9555008-B2 Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-01-31 US disclosed
US-20160256402-A1 SYNTHESIS OF HYPERBRANCHED AMPHIPHILIC POLYESTER AND THERANOSTIC NANOPARTICLES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-09-08 US disclosed
US-9267002-B2 Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-02-23 US disclosed
US-9095611-B1 Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof THE UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160256402-A1 SYNTHESIS OF HYPERBRANCHED AMPHIPHILIC POLYESTER AND THERANOSTIC NANOPARTICLES THEREOF LIPA, DLST, ANXA6 ALDH1A1 2409/4885DDAH1 107/4885TSHR 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.